Sogué Coulibaly

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

Annett Hessel, Helga Savidis-Dacho, Sogué Coulibaly et al. · PLoS ONE · 2014 · 63 citations · Full text

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity

Annett Hessel, Michael G. Schwendinger, Georg W. Holzer et al. · PLoS ONE · 2011 · 51 citations · Full text

Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection

Georg W. Holzer, Sogué Coulibaly, Gerald Aichinger et al. · Vaccine · 2011 · 36 citations

Vaccination, Vaccinology, Vaccine Development +6

A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations

Annett Hessel, Michael G. Schwendinger, D. Fritz et al. · PLoS ONE · 2010 · 31 citations · Full text

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever

Birgit Schäfer, Georg W. Holzer, Alexandra Joachimsthaler et al. · PLoS ONE · 2011 · 31 citations · Full text